$CDLX
Cardlytics, Inc.

2023 Q3 Form 10-Q Financial Statement

#000166607123000105 Filed on August 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $79.01M $76.70M $75.41M
YoY Change 8.66% 1.72% 28.12%
Cost Of Revenue $36.14M $39.17M $40.28M
YoY Change -3.79% -2.76% 37.84%
Gross Profit $42.86M $37.53M $35.13M
YoY Change 21.96% 6.85% 18.55%
Gross Profit Margin 54.25% 48.93% 46.58%
Selling, General & Admin $29.72M $38.50M $42.97M
YoY Change -22.32% -10.41% 26.56%
% of Gross Profit 69.35% 102.57% 122.33%
Research & Development $12.43M $14.85M $13.58M
YoY Change -9.68% 9.32% 52.01%
% of Gross Profit 29.0% 39.56% 38.66%
Depreciation & Amortization $5.990M $7.200M $10.36M
YoY Change -42.78% -30.48% 17.31%
% of Gross Profit 13.98% 19.18% 29.48%
Operating Expenses $42.15M $71.80M $56.55M
YoY Change -18.97% 26.97% 31.86%
Operating Profit -$20.65M -$34.27M -$122.3M
YoY Change -279.27% -71.98% 176.56%
Interest Expense -$3.310M $815.0K -$5.417M
YoY Change -36.99% -115.05% 75.99%
% of Operating Profit
Other Income/Expense, Net -$3.314M $815.0K -$5.417M
YoY Change -36.91% -115.05% 75.99%
Pretax Income -$23.97M -$23.51M -$127.7M
YoY Change -482.42% -81.6% 170.02%
Income Tax $0.00 $0.00 -$1.446M
% Of Pretax Income
Net Earnings -$23.97M -$23.51M -$126.3M
YoY Change -482.42% -81.39% 166.96%
Net Earnings / Revenue -30.33% -30.65% -167.48%
Basic Earnings Per Share -$0.63 -$0.67 -$3.75
Diluted Earnings Per Share -$0.63 -$0.67 -$3.75
COMMON SHARES
Basic Shares Outstanding 37.72M shares 33.91M shares 34.12M shares
Diluted Shares Outstanding 37.98M shares 34.88M shares 33.64M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.10M $92.07M $157.0M
YoY Change -34.95% -41.37% -37.34%
Cash & Equivalents $90.07M $92.07M $157.0M
Short-Term Investments
Other Short-Term Assets $7.400M $7.900M $9.739M
YoY Change -15.63% -18.88% 18.15%
Inventory
Prepaid Expenses
Receivables $103.3M $97.28M $92.21M
Other Receivables $4.865M $4.466M $4.955M
Total Short-Term Assets $205.6M $201.7M $263.9M
YoY Change -17.48% -23.58% -22.02%
LONG-TERM ASSETS
Property, Plant & Equipment $3.005M $7.911M $8.619M
YoY Change -57.69% -8.21% -34.18%
Goodwill $352.7M $352.7M $665.8M
YoY Change -47.02% -47.02% -7.33%
Intangibles $43.12M $46.56M $121.0M
YoY Change -62.14% -61.53% -11.76%
Long-Term Investments
YoY Change
Other Assets $1.941M $2.493M $3.106M
YoY Change -29.08% -19.74% 18.69%
Total Long-Term Assets $429.3M $431.6M $825.6M
YoY Change -47.46% -47.72% -7.7%
TOTAL ASSETS
Total Short-Term Assets $205.6M $201.7M $263.9M
Total Long-Term Assets $429.3M $431.6M $825.6M
Total Assets $634.9M $633.3M $1.090B
YoY Change -40.46% -41.87% -11.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.479M $1.698M $2.810M
YoY Change -27.03% -39.57% -46.14%
Accrued Expenses $9.666M $22.04M $20.96M
YoY Change -52.98% 5.14% 155.43%
Deferred Revenue $3.323M $3.015M $4.654M
YoY Change 10.62% -35.22% 67.59%
Short-Term Debt $30.00M $30.00M $0.00
YoY Change
Long-Term Debt Due $0.00 $37.00K $37.00K
YoY Change -100.0% 0.0% 60.87%
Total Short-Term Liabilities $179.5M $167.9M $293.5M
YoY Change -29.59% -42.79% 11.62%
LONG-TERM LIABILITIES
Long-Term Debt $227.1M $226.8M $225.3M
YoY Change 0.62% 0.64% 25.78%
Other Long-Term Liabilities $3.000M $2.516M $28.00K
YoY Change 14185.71% 8885.71% -95.88%
Total Long-Term Liabilities $230.1M $229.3M $28.00K
YoY Change 1095614.29% 818792.86% -95.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $179.5M $167.9M $293.5M
Total Long-Term Liabilities $230.1M $229.3M $28.00K
Total Liabilities $409.6M $397.2M $525.4M
YoY Change -15.69% -24.39% 1.33%
SHAREHOLDERS EQUITY
Retained Earnings -$1.010B -$986.5M -$604.6M
YoY Change 68.89% 63.17% 29.66%
Common Stock $1.230B $1.220B $1.163B
YoY Change 5.24% 4.85% -1.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $225.3M $236.1M $564.2M
YoY Change
Total Liabilities & Shareholders Equity $634.9M $633.3M $1.090B
YoY Change -40.46% -41.87% -11.63%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$23.97M -$23.51M -$126.3M
YoY Change -482.42% -81.39% 166.96%
Depreciation, Depletion And Amortization $5.990M $7.200M $10.36M
YoY Change -42.78% -30.48% 17.31%
Cash From Operating Activities $1.190M $5.751M -$6.678M
YoY Change -108.24% -186.12% -55.42%
INVESTING ACTIVITIES
Capital Expenditures $3.150M $2.747M -$4.269M
YoY Change -195.34% -164.35% 44.76%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$3.150M -$2.747M -$4.269M
YoY Change -4.66% -35.65% -98.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $40.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.00K -50.08M -39.98M
YoY Change -600.0% 25.24% -5554.84%
NET CHANGE
Cash From Operating Activities 1.190M 5.751M -6.678M
Cash From Investing Activities -3.150M -2.747M -4.269M
Cash From Financing Activities 30.00K -50.08M -39.98M
Net Change In Cash -1.930M -47.07M -50.93M
YoY Change -89.12% -7.58% -85.96%
FREE CASH FLOW
Cash From Operating Activities $1.190M $5.751M -$6.678M
Capital Expenditures $3.150M $2.747M -$4.269M
Free Cash Flow -$1.960M $3.004M -$2.409M
YoY Change -82.39% -224.7% -79.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15171000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1104000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1281000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-23508000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
690700000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
421000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27859000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1503000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5094000 usd
us-gaap Net Income Loss
NetIncomeLoss
-93252000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
711670000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
226000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13321000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1503000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3727000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-126290000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
564157000 usd
us-gaap Net Income Loss
NetIncomeLoss
-93252000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9900000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1041000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
744000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20227000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13775000 usd
cdlx Capitalized Contract Cost Amortization Interest Expense
CapitalizedContractCostAmortizationInterestExpense
790000 usd
cdlx Capitalized Contract Cost Amortization Interest Expense
CapitalizedContractCostAmortizationInterestExpense
819000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2939000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2205000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
26427000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
19707000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
83149000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-68018000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-23326000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6087000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3147000 usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-1446000 usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-19663000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18069000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1885000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-430000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1821000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2046000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5770000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-10954000 usd
cdlx Increase Decrease In Financial Institution Share Liability
IncreaseDecreaseInFinancialInstitutionShareLiability
-4821000 usd
cdlx Increase Decrease In Financial Institution Share Liability
IncreaseDecreaseInFinancialInstitutionShareLiability
269000 usd
cdlx Increase Decrease In Consumer Incentive Liability
IncreaseDecreaseInConsumerIncentiveLiability
-9679000 usd
cdlx Increase Decrease In Consumer Incentive Liability
IncreaseDecreaseInConsumerIncentiveLiability
-10958000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4313000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
6083000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2274000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9303000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5549000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
30000000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
50050000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
21000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
11000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
393000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
45000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
40000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
174000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-39802000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20095000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-969000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-76443000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29840000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233562000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121985000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157119000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92145000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157038000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92069000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
81000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
76000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157119000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92145000 usd
us-gaap Interest Paid Net
InterestPaidNet
1188000 usd
us-gaap Interest Paid Net
InterestPaidNet
1924000 usd
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
11937000 usd
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
0 usd
CY2023Q2 cdlx First Anniversary Annualized Recurring Revenue Cash Paid
FirstAnniversaryAnnualizedRecurringRevenueCashPaid
50100000 usd
CY2023Q2 cdlx Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered
BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered
2740418 shares
CY2023Q2 cdlx First Anniversary Annualized Recurring Revenue Cash Paid
FirstAnniversaryAnnualizedRecurringRevenueCashPaid
50100000 usd
CY2023Q2 cdlx Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered
BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered
2740418 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Significant items subject to such estimates and assumptions include revenue recognition, internal-use software development costs, stock-based compensation, allowance for doubtful accounts, valuation of acquired intangible assets, valuation of contingent consideration for Bridg, goodwill impairment, income tax including valuation allowance, and contingencies. We base our estimates on historical experience and on assumptions that we believe are reasonable. Changes in facts or circumstances may cause us to change our assumptions and estimates in future periods and it is possible that actual results could differ from our current or revised future estimates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Macroeconomic Considerations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unfavorable conditions in the economy both in the United States and abroad may negatively affect the growth of our business and our results of operations. For example, macroeconomic events, including the changes in inflation, the U.S. Federal Reserve raising interest rates, disruptions in access to bank deposits or lending commitments due to bank failures and the Russia-Ukraine war have led to economic uncertainty globally. Historically, during periods of economic uncertainty and downturns, businesses may slow spending on advertising, which may impact our business and our customers’ businesses.</span></div>The effect of macroeconomic conditions may not be fully reflected in our results of operations until future periods. If, however, economic uncertainty increases or the global economy worsens, our business, financial condition and results of operations may be harmed. For further discussion of the potential impacts of macroeconomic events on our business, financial condition and operating results, see the section titled "Risk Factors.
CY2022Q2 cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
2200000 usd
CY2023Q2 cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
-9900000 usd
CY2023Q2 cdlx First Anniversary Annualized Recurring Revenue Cash Paid
FirstAnniversaryAnnualizedRecurringRevenueCashPaid
50100000 usd
CY2023Q2 cdlx Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered
BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered
2740418 shares
CY2022Q1 us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
24000 usd
CY2022Q1 us-gaap Proceeds From Limited Partnership Investments
ProceedsFromLimitedPartnershipInvestments
61000 usd
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
748963000 usd
CY2023Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
396242000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
352721000 usd
CY2022Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
83100000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
313100000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
92300000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
45827000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
154500000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
44732000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
53373000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6826000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
13603000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
11808000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9673000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4563000 usd
CY2023Q2 cdlx Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
0 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46473000 usd
CY2022Q2 cdlx Consumer Incentives Expense
ConsumerIncentivesExpense
32300000 usd
CY2023Q2 cdlx Consumer Incentives Expense
ConsumerIncentivesExpense
32700000 usd
cdlx Consumer Incentives Expense
ConsumerIncentivesExpense
62600000 usd
cdlx Consumer Incentives Expense
ConsumerIncentivesExpense
64000000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69270000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70726000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
133253000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
129756000 usd
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
28000 usd
CY2023Q2 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
633000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2084000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3099000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
13400000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6571000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4510000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
48000 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
29000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
6619000 usd
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
4539000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4910000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3002000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4306000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2432000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
38000 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
37000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3000 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 usd
CY2023Q2 cdlx Net Rentable Area Leased
NetRentableAreaLeased
77000 sqft
CY2023Q2 cdlx Net Rentable Area Leased
NetRentableAreaLeased
17000 sqft
CY2023Q2 cdlx Reduction Of Minimum Lease Payments
ReductionOfMinimumLeasePayments
1900000 usd
cdlx Lease Reduction In Expense
LeaseReductionInExpense
700000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
30000000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
226047000 usd
CY2023Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
226774000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
226047000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
256774000 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
700000 usd
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
230000000 usd
CY2020Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0100
CY2020Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
222700000 usd
CY2020Q3 cdlx Adjustments To Additional Paid In Capital Issuance Of Capped Calls
AdjustmentsToAdditionalPaidInCapitalIssuanceOfCappedCalls
26500000 usd
CY2020Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0100
CY2020Q3 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
10000 numberofdays
CY2020Q3 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
0.98
CY2020Q3 us-gaap Debt Instrument Convertible Conversion Ratio1
DebtInstrumentConvertibleConversionRatio1
11.7457
CY2020Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
85140
CY2020Q3 cdlx Debt Instrument Convertible Redemption Period Days Before Maturity Date
DebtInstrumentConvertibleRedemptionPeriodDaysBeforeMaturityDate
P36D
CY2020Q3 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1
CY2023Q2 cdlx Debt Instrument Convertible Threshold Principal Outstanding Amount For Partial Redemption
DebtInstrumentConvertibleThresholdPrincipalOutstandingAmountForPartialRedemption
75000000 usd
CY2020Q3 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1
CY2020Q3 cdlx Debt Instrument Required Compliance Period Period After Written Notice
DebtInstrumentRequiredCompliancePeriodPeriodAfterWrittenNotice
P60D
CY2020Q3 cdlx Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance
DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance
0.25
CY2020Q3 cdlx Debt Instrument Convertible Redemption Requirement Amount Of Other Debt Called Due
DebtInstrumentConvertibleRedemptionRequirementAmountOfOtherDebtCalledDue
35000000 usd
CY2020Q3 cdlx Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance
DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance
0.25
cdlx Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance
DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance
0.25
cdlx Debt Instrument Convertible Covenant Noncompliance Period Of Additional Interest
DebtInstrumentConvertibleCovenantNoncompliancePeriodOfAdditionalInterest
P365D
cdlx Debt Instrument Convertible Liability Component Discount Rate
DebtInstrumentConvertibleLiabilityComponentDiscountRate
0.0650
CY2022Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
575000 usd
CY2023Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
575000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1150000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1150000 usd
CY2022Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
365000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
365000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
730000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
730000 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
940000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
940000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
1880000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
1880000 usd
CY2022Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0164
CY2023Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0164
CY2022Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0164
CY2023Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0164
CY2020Q3 cdlx Adjustments To Additional Paid In Capital Issuance Of Capped Calls
AdjustmentsToAdditionalPaidInCapitalIssuanceOfCappedCalls
26500000 usd
CY2020Q3 us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
85.14
CY2020Q3 cdlx Option Indexed To Issuers Equity Cap Price
OptionIndexedToIssuersEquityCapPrice
128.51
CY2023Q2 cdlx Line Of Credit Facility Maximum Borrowing Capacity Percentage Of Eligible Accounts Receivable
LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleAccountsReceivable
0.50
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
30000000 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
600000 usd
CY2023Q2 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
7000000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
405830 shares
CY2023Q2 cdlx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Annual Percentage Increase
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedAnnualPercentageIncrease
0.05
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1673858 shares
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12842000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11739000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26427000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19707000 usd
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
800000 usd
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1000000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7380000 shares
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
396200000 usd
CY2023Q1 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
69537000 usd
CY2021Q4 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
232295000 usd
CY2022Q4 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
104121000 usd
CY2022Q2 us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
0 usd
CY2023Q2 us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
-61808000 usd
us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
0 usd
us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
-61808000 usd
CY2022Q2 us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-2968000 usd
CY2023Q2 us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
11258000 usd
CY2022Q2 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
164277000 usd
CY2023Q2 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
18987000 usd
CY2023Q2 cdlx First Anniversary Annualized Recurring Revenue Cash Paid
FirstAnniversaryAnnualizedRecurringRevenueCashPaid
50100000 usd
CY2023Q2 cdlx Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered
BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered
2740418 shares
CY2023Q2 cdlx First Anniversary Annualized Recurring Revenue Cash Paid
FirstAnniversaryAnnualizedRecurringRevenueCashPaid
50100000 usd
CY2023Q2 cdlx Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered
BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered
2740418 shares
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
230000000 usd
CY2020Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0100
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2022Q2 cdlx Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs
FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts
40280000 usd
CY2022Q2 us-gaap Revenues
Revenues
75405000 usd
CY2023Q2 us-gaap Revenues
Revenues
76701000 usd
us-gaap Revenues
Revenues
143333000 usd
us-gaap Revenues
Revenues
141032000 usd
CY2022Q2 cdlx Delivery Costs
DeliveryCosts
8162000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21983000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13581000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20984000 usd
CY2022Q2 cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
2197000 usd
CY2022Q2 cdlx Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-2968000 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
83149000 usd
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
83149000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7200000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
20227000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
13775000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
815000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8034000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2196000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23508000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-94698000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9900000 usd
CY2023Q2 us-gaap Revenues
Revenues
76701000 usd
us-gaap Revenues
Revenues
143333000 usd
us-gaap Revenues
Revenues
141032000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5916000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3401000 usd
CY2023Q2 cdlx Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered
BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered
2740418 shares

Files In Submission

Name View Source Status
0001666071-23-000105-index-headers.html Edgar Link pending
0001666071-23-000105-index.html Edgar Link pending
0001666071-23-000105.txt Edgar Link pending
0001666071-23-000105-xbrl.zip Edgar Link pending
cdlx-20230630.htm Edgar Link pending
cdlx-20230630.xsd Edgar Link pending
cdlx-20230630_g1.jpg Edgar Link pending
cdlx_form10-qx2023q2xex102.htm Edgar Link pending
cdlx_form10-qx2023q2xex103.htm Edgar Link pending
cdlx_form10-qx2023q2xex311.htm Edgar Link pending
cdlx_form10-qx2023q2xex312.htm Edgar Link pending
cdlx_form10-qx2023q2xex321.htm Edgar Link pending
cdlx_formx10-qx2023q2xex101.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
image_0a.jpg Edgar Link pending
image_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
cdlx-20230630_cal.xml Edgar Link unprocessable
cdlx-20230630_def.xml Edgar Link unprocessable
cdlx-20230630_lab.xml Edgar Link unprocessable
cdlx-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cdlx-20230630_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending